The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Universal Biosensors (UBI) has signed a distribution agreement with Vines to Vintages for the distribution of its wine-testing platform, Sentia, in Canada
  • Sentia analyses sulfur dioxide in post-fermentation red or white wine
  • The agreement is for three years and includes standard renewal and termination options
  • On the market, UBI is up 1.96 per cent and is trading at 52 cents per share

Universal Biosensors (UBI) has signed a distribution agreement with Vines to Vintages for the distribution of its wine-testing platform device, Sentia, in Canada.

Vines to Vintages is an independent wine laboratory performing analysis for wineries in Canada and United States. It also sells winemaking supplies and equipment.

Sentia analyses sulfur dioxide in post-fermentation red or white wine. The product is then able to display, through a touchscreen, the test results in under a minute.

Sulfur dioxide is added in the winemaking process to protect the wine from oxidation and bacterial spoilage.

The agreement is for three years and includes standard renewal and termination options.

UBI CEO John Sharman said this is another positive step in the commercialisation of Sentia globally.

“Vines to Vintages is well represented in all of Canada’s wine regions and has access to 700 wineries. The deal includes an initial commitment to purchase
Sentia devices and strips which will be delivered over the course of the next few weeks,” he said.

“We believe the possibility of Sentia’s future testing capability for Glucose,
Fructose, Malic Acid and others will add significant value to the winemaking industry,” he added.

UBI is currently negotiating terms with a number of key industry players around the world and looks forward to reporting additional distribution partnerships in the future.

On the market, UBI is up 1.96 per cent and is trading at 52 cents per share at 2:49 pm AEDT.

UBI by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…